ÀÎÁö Áø´Ü ½ÃÀå : ºÎ¹®º°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
Cognitive Diagnostics Market, By Diagnosis, By Indication, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1555527
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 303 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,590,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,568,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,980,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

2023³â ÀÎÁö Áø´Ü(Cognitive Diagnostics) ½ÃÀå ±Ô¸ð´Â 53¾ï 9,021¸¸ ´Þ·¯¿´À¸¸ç, 2024³âºÎÅÍ 2032³â±îÁö CAGR 27.90%·Î ÃßÀÌÇϸç È®´ë

ÀÎÁö Áø´Ü ½ÃÀå-½ÃÀå ¿ªÇÐ

¼¼°è ³ëÀÎ Àα¸ Áõ°¡¿Í ÀÎÁö Àå¾Ö À¯º´·ü Áõ°¡°¡ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ Àü¸Á

¼¼°èÀÇ Àα¸µ¿Å´ ±Þ¼ÓÇÑ °í·ÉÈ­ °æÇâ¿¡ ÀÖ¾î, ³ëÀÎ Àα¸ Áõ°¡°¡ ÇöÀúÇÕ´Ï´Ù. ÀÌ Àα¸ ¿ªÇÐÀÇ º¯È­·Î ÀÎÇØ ³ëÀεéÀº ¾ËÃ÷ÇÏÀÌ¸Ó º´°ú ´Ù¾çÇÑ Ä¡¸Å¸¦ Æ÷ÇÔÇÑ ÀÎÁö Àå¾ÖÀÇ À§ÇèÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)´Â 2030³â±îÁö ¼¼°è 6¸í Áß 1¸íÀÌ 60¼¼ ÀÌ»óÀÌ µÉ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ±× °á°ú 60¼¼ ÀÌ»óÀÇ Àα¸´Â 2020³â 10¾ï ¸í¿¡¼­ 14¾ï ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÎÁö Àå¾ÖÀÇ ÀÎÁöµµ Çâ»ó°ú Áø´Ü ¹æ¹ýÀÇ Áøº¸´Â ÀÎÁö Àå¾ÖÀÇ Æ¯Á¤ ºñÀ²ÀÇ Çâ»ó¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Áø´Ü±â¼úÀÇ ÁøÈ­¿¡ µû¶ó, º¸´Ù ¸¹Àº »ç·Ê°¡ ÀÎ½ÄµÇ¾î º¸´Ù ºü¸¥ ´Ü°è¿¡¼­ Áø´ÜµÇ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, ÇöÀç ÁøÇà ÁßÀÎ ±â¼ú Çõ½Å°ú ÀÇ·á ÀÎÇÁ¶óÀÇ È®ÃæÀº ½ÃÀå ¼ºÀåÀÇ Å« ±âȸ°¡ µÇ°í ÀÖ½À´Ï´Ù. ±×·³¿¡µµ ºÒ±¸Çϰí Ç¥ÁØÈ­°¡ ÁøÇàµÇÁö ¾ÊÀº °æ¿ì ½ÃÀå È®´ë¿¡ ¹®Á¦°¡ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÎÁö Áø´Ü ½ÃÀå-ÁÖ¿ä ÀλçÀÌÆ®

Á¶»ç ºÐ¼®°¡ÀÇ ºÐ¼®¿¡ µû¸£¸é ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032³â) µ¿¾È CAGR ¾à 27.90%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â °¡Àå ¸¹Àº ¼öÀÍÀ» âÃâÇß½À´Ï´Ù.

ÀÎÁö Áø´Ü ½ÃÀå-¼¼ºÐÈ­ ºÐ¼® :

¼¼°èÀÇ ÀÎÁö Áø´Ü ½ÃÀåÀº Áø´Ü, ÀûÀÀÁõ, ÃÖÁ¾ »ç¿ëÀÚ ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

³ú¿µ»ó°Ë»ç, ÀÓ»ó°Ë»ç, Á¤½Å»óŰ˻ç, ½Å¼Ó Ȩ½ºÅ©¸®´×°Ë»ç, ½Å°æ½É¸®ÇÐÀû °Ë»ç, ³úÆÄ(EEG), ÀÎÁö±â´É¡¤Çൿ°Ë»ç, NPI-Q(Neuropsychiatric Inventory Questionnaire). ÀÌ·¯ÇÑ Áø´Ü ¹üÁÖ´Â °¢°¢ öÀúÇÑ Æò°¡¸¦ Á¦°øÇϰí ÀÎÁö °Ç°­ ¿µ¿ª¿¡¼­ ȯÀÚ °á°ú¸¦ Çâ»ó½ÃŰ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.

½ÃÀåÀº ÀûÀÀÁõº°·Î µÎ °¡Áö ¹üÁÖ·Î ºÐ·ùµË´Ï´Ù : ¾ËÃ÷ÇÏÀÌ¸Ó º´, Ä¡¸Å ¹× ±âŸ ½Å°æ Áúȯ. °¢ Ä«Å×°í¸®¿¡´Â ÀÌ·¯ÇÑ Áúº´À» Æò°¡Çϰí Ä¡·áÇϱâ À§ÇÑ ¸íÈ®ÇÑ Áø´Ü µµ±¸ ¹× ¹æ¹ýÀÌ Æ÷ÇԵ˴ϴÙ.

ÃÖÁ¾ »ç¿ëÀÚº°·Î´Â º´¿ø, ½Å°æ°ú Ŭ¸®´Ð, ÀçȰ¼¾ÅÍ, Çмú±â°ü ¹× ¿¬±¸±â°ü, ÀçÅà ÄÉ¾î µîÀ¸·Î ºÐ·ùµË´Ï´Ù. °¢ ÃÖÁ¾ »ç¿ëÀÚ ±×·ìÀº ƯÁ¤ ¿ä±¸ »çÇ×°ú ȯ°æ¿¡ ¸Â°Ô ¸ÂÃãÈ­µÈ ´Ù¸¥ Áø´Ü µµ±¸¿Í ±â¼úÀ» äÅÃÇÕ´Ï´Ù.

ÀÎÁö Áø´Ü ½ÃÀå-Áö¸®Àû ÅëÂû

½ÃÀåÀº Áö¸®ÀûÀ¸·Î ºÏ¹Ì, Áß³²¹Ì, À¯·´, ¾Æ½Ã¾Æ ÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«·Î ÆÛÁ® ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ºñÁî´Ï½º ¸ñÀûÀ¸·Î ±¹°¡º°·Î ³ª´µ¾îÁ® ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â ÀÎÁö ´É·ÂÀ» Æò°¡ÇÏ´Â Áø´Ü µµ±¸¿Í ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ½ÃÀå ¼ºÀåÀ» À̲ø°í ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ƯÈ÷ ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×¿¡¼­ ±â¼ú Áøº¸ÀÇ °³Ã´ÀÚÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ÀÎÁö Áø´Ü µµ±¸¿¡ ÅëÇյǾî Á¤È®¼º°ú È¿À²¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. Ç»¸®¼­Ä¡°¡ ½Ç½ÃÇÑ Á¶»ç¿¡ µû¸£¸é ¹Ì±¹ÀÎÀÇ 55%°¡ AI¸¦ Á¤±âÀûÀ¸·Î »ç¿ëÇϰí ÀÖ´Ù°í ÁÖÀåÇÏ´Â ¹Ý¸é 44%´Â Á¤±âÀûÀ¸·Î »ç¿ëÇÏÁö ¾Ê´Â´Ù°í »ý°¢ÇÏ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. À¯·´Àº °³ÀÎÈ­µÈ ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå ¼ºÀåÀÇ µÎ ¹øÂ° ÀÚ¸®°¡ µÇ¾ú½À´Ï´Ù.

ÀÎÁö Áø´Ü ½ÃÀå-°æÀï ȯ°æ :

ÀÎÁö Áø´Ü ½ÃÀåÀº Ä¡¿­ÇÑ °æÀï»óÅ¿¡ ÀÖÀ¸¸ç, Æø³ÐÀº °æÀï¾÷üµéÀÌ ±â¼úÀû Áøº¸, Àü·«Àû Á¦ÈÞ, Á¦Ç°Â÷º°È­¸¦ ÅëÇØ ½ÃÀå Á¡À¯À²À» ȹµæÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. °¢ ȸ»ç´Â Çõ½ÅÀûÀÎ Áø´Ü Àåºñ¿Í ±â¼úÀ» µµÀÔÇϱâ À§ÇÑ ¿¬±¸ °³¹ß¿¡ ¾öû³­ ÀÚ¿øÀ» ÅõÀÔÇϰí ÀÖ½À´Ï´Ù. ¿©±â¿¡´Â ³ú ¿µ»ó, ¹ÙÀÌ¿À¸¶Ä¿ ºÐ¼®, AI¸¦ Ȱ¿ëÇÑ Áø´Ü ½Ã½ºÅÛÀÇ ¹ßÀüÀÌ Æ÷ÇԵ˴ϴÙ. ±â¾÷Àº ½ÅÈï ½ÃÀåÀ¸·Î ÁøÃâÇϰí ÀÎÁö Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ´Â Áö¿ª¿¡¼­ ÇÁ·¹Á𽺸¦ È®¸³ÇÔÀ¸·Î½á ½ÃÀå¹üÀ§¸¦ ³ÐÈ÷°í ÀÖ½À´Ï´Ù. ¿©±â¿¡´Â »õ·Î¿î ½Ã¼³ ¼³¸³, ÇöÁö ±â¾÷ Àμö, Áö¿ª ¿ä±¸ »çÇ׿¡ ¸Â´Â Á¦Ç° ¸ÂÃã¼³Á¤ µîÀÌ Æ÷ÇԵ˴ϴÙ. °¢ ȸ»ç´Â µ¶Æ¯ÇÑ Áø´Ü Àåºñ °³¹ß, Á¤È®¼º Çâ»ó, »ç¿ëÀÚ Ä£È­Àû ÀÎ ÀÎÅÍÆäÀ̽º ¹× ´Ù¸¥ °Ç°­ °ü¸® ±â¼ú°úÀÇ ¿øÈ°ÇÑ ÅëÇÕÀ» ÅëÇØ Ÿ»ç¿ÍÀÇ Â÷º°È­¸¦ µµ¸ðÇϰí ÀÖ½À´Ï´Ù. ¿©±â¿¡´Â ÀÎÁö Æò°¡ÀÇ ´Ù¾çÇÑ Ãø¸é¿¡ ´ëÀÀÇÏ´Â Á¾ÇÕÀûÀÎ Áø´Ü ¼Ö·ç¼Ç Á¦°øµµ Æ÷ÇԵ˴ϴÙ.

¸ñÂ÷

Á¦1Àå ÀÎÁö Áø´Ü ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÀÎÁö Áø´Ü-ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ÀÎÁö Áø´Ü »ê¾÷ ¿¬±¸

Á¦5Àå ÀÎÁö Áø´Ü ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå ÀÎÁö Áø´Ü ½ÃÀå »óȲ

Á¦7Àå ÀÎÁö Áø´Ü ½ÃÀå-Áø´Üº°

Á¦8Àå ÀÎÁö Áø´Ü ½ÃÀå-ÀûÀÀÁõº°

Á¦9Àå ÀÎÁö Áø´Ü ½ÃÀå-ÃÖÁ¾ »ç¿ëÀÚº°

Á¦10Àå ÀÎÁö Áø´Ü ½ÃÀå-Áö¿ªº°

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼®-ÀÎÁö Áø´Ü »ê¾÷

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

LYJ
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Cognitive Diagnostics Market size was valued at USD 5,390.21 million in 2023, expanding at a CAGR of 27.90% from 2024 to 2032.

Cognitive diagnostic models are a psychometric paradigm for designing and scoring tests to provide a profile of examinee skill mastery rather than just an overall test score. Cognitive diagnostics refers to the assessment and evaluation of cognitive functions, which include memory, attention, language, problem-solving, and other intellectual abilities. This field encompasses various techniques, tools, and technologies used to diagnose cognitive impairments and disorders, such as Alzheimer's disease, dementia, ADHD, and other neurological conditions. Cognitive diagnostics play a crucial role in the management and treatment of cognitive disorders, offering valuable insights into brain health and function. As technology advances, the field is expected to grow, providing more accurate, accessible, and affordable diagnostic options.

Cognitive Diagnostics Market- Market Dynamics

The growing geriatric population and increasing prevalence of cognitive disorders globally are expected to drive the growth of the market

The global demographic landscape is experiencing a swift aging trend, marked by a notable rise in the elderly population. This demographic shift places older adults at an elevated risk for cognitive impairments, including Alzheimer's disease and various forms of dementia. The World Health Organization projects that by the year 2030, one in six individuals worldwide will be aged 60 years or older. Consequently, the population segment aged 60 and above is expected to grow from 1 billion in 2020 to 1.4 billion. Enhanced awareness and advancements in diagnostic methods are contributing to higher rates of identification for cognitive disorders. As diagnostic technologies evolve, more cases are being recognized and diagnosed at earlier stages-additionally, the ongoing technological innovations and the expansion of healthcare infrastructure present significant opportunities for market growth. Nevertheless, the absence of standardization may pose challenges to the market's expansion.

Cognitive Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 27.90% over the forecast period (2024-2032)

Based on region, North America was the leading revenue generator in 2023

Cognitive Diagnostics Market- Segmentation Analysis:

The Global Cognitive Diagnostics Market is segmented based on Diagnosis, Indication, End-User, and Region.

The market is segmented into eight distinct categories according to Diagnosis: Brain Imaging Tests, Laboratory Testing, Mental Status Testing, Rapid Home Screening Tests, Neuropsychological Testing, Electroencephalogram (EEG), Cognitive Function & Behavioral Tests, and the Neuropsychiatric Inventory Questionnaire (NPI-Q). Each of these diagnostic categories is essential for delivering thorough evaluations and enhancing patient outcomes in the realm of cognitive health.

The market is segmented into two categories according to Indication: Alzheimer's disease, Dementia, and other neurological disorders. Each category includes distinct diagnostic tools and methods for evaluating and treating these conditions.

The market is segmented into two groups according to End-User: Hospitals, Neurology Clinics, Rehabilitation Centers, Academic and Research Institutes, Home Care, and Others. Each end-user group employs different diagnostic tools and techniques customized to their particular requirements and environments.

Cognitive Diagnostics Market- Geographical Insights

The market is geographically spread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented by countries for business purposes. North America leads the market growth, driven by the increasing demand for diagnostic tools and technologies to assess cognitive performance. The region is a pioneer in technological advancements, especially in artificial intelligence (AI) and machine learning. These technologies are being incorporated into cognitive diagnostic tools, improving their precision and effectiveness. A survey conducted by Pew Research revealed that 55% of Americans claim to regularly use AI, while 44% believe they do not use it regularly. Europe follows as the second largest region for market growth, attributed to the rising demand for Personalized Medicine.

Cognitive Diagnostics Market- Competitive Landscape:

The cognitive diagnostics market is fiercely competitive, with a wide array of competitors striving to gain market share through technological advancements, strategic alliances, and product distinctiveness. Organizations are dedicating significant resources to research and development to introduce innovative diagnostic instruments and technologies. This encompasses progress in brain imaging, biomarker analysis, and AI-powered diagnostic systems. Businesses are broadening their market reach by venturing into emerging markets and establishing a presence in regions where there is a growing demand for cognitive diagnostics. This involves establishing new facilities, acquiring local entities, and customizing products to suit regional requirements. Companies set themselves apart by creating unique diagnostic instruments, enhancing precision, user-friendly interfaces, and seamless integration with other healthcare technologies. This includes providing comprehensive diagnostic solutions that address various aspects of cognitive evaluation.

Recent Developments:

C2N Diagnostics, a prominent entity in the field of advanced brain health diagnostics known for its PrecivityAD blood test, which assists in the diagnosis of Alzheimer's disease, has unveiled its latest innovative product. This new offering is expected to significantly improve care for individuals experiencing cognitive impairment: a high-resolution mass spectrometry-based plasma tau multi-analyte assay (p-tau MAA) designated for Research Use Only (RUO).

Cognetivity Neurosciences Ltd., a technology company specializing in brain health screening platforms for medical, commercial, and consumer settings, is excited to share that its leading CognICA tool has proven to be effective in monitoring cognitive function in Alzheimer's disease patients undergoing treatment with the disease-modifying therapy Aduhelm (aducanumab) from Biogen.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL COGNITIVE DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL COGNITIVE DIAGNOSTICS MARKET, BY DIAGNOSIS- MARKET ANALYSIS, 2019 - 2032

GLOBAL COGNITIVE DIAGNOSTICS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

GLOBAL COGNITIVE DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Cognitive Diagnostics Market Overview

2. Executive Summary

3. Cognitive Diagnostics Key Market Trends

4. Cognitive Diagnostics Industry Study

5. Cognitive Diagnostics Market: COVID-19 Impact Analysis

6. Cognitive Diagnostics Market Landscape

7. Cognitive Diagnostics Market - By Diagnosis

8. Cognitive Diagnostics Market - By Indication

9. Cognitive Diagnostics Market - By End-User

10. Cognitive Diagnostics Market- By Geography

11. Key Vendor Analysis- Cognitive Diagnostics Industry

12. 360 Degree Analyst View

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â